TheHerdLocker.com Skip to content…
  • Recent
  • Popular
The most popular thoughts. Popular rankings for #oncology show you the articles which have had the most shares over the past 7 days, 30 days or the past 6-7 months.

We show you the original tweet, and the 'share' number is the number of times that the content was linked to by other twitter users: as retweets, duplicate posts, shortened URLs and so on.

Remember to check out the recent reports, showing the latest filtered tweets as fast as we can process them.

7 days 30 days 6 months+

Busy? Get Free Weekly Reports

    Previous1..45678910..16Next
First Shared by Shares URL Content Date
@CancerWallonia 0 https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/costimulatory-agonists-start-to-bear-fruit-in-oncology #Costimulatory #Agonists Start to Bear Fruit in #Oncology (followed by Marc #Lacroix, #Wallonia) https://shar.es/aaVH9T 12-Jan-19 12:51 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/expert-explores-future-of-cdk46-inhibitors-in-breast-cancer Expert Explores Future of #CDK4/6 #Inhibitors in #Breast #Cancer https://shar.es/aaVHFb #oncology 12-Jan-19 12:51 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/pomalidomide-shows-benefit-in-lenalidomiderefractory-myeloma #Pomalidomide Shows Benefit in #Lenalidomide-Refractory #Myeloma https://shar.es/aaVHRG #oncology 12-Jan-19 12:52 Open Tweet
@CancerWallonia 0 https://www.onclive.com/publications/special-issues/2019/inhibition-of-the-bcl-2-pathway-in-hematologic-malignancies/targeting-bcl2-in-hematologic-malignancies Targeting #BCL-2 in #Hematologic #Malignancies https://shar.es/aaVHBx #oncology 12-Jan-19 12:52 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/few-unanswered-questions-remain-for-nonmetastatic-prostate-cancer Few Unanswered Questions Remain for #Nonmetastatic #Prostate #Cancer https://shar.es/aaVHTA #oncology 12-Jan-19 12:53 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/expert-discusses-neoadjuvant-chemo-cystectomy-in-localized-bladder-cancer Expert Discusses #Neoadjuvant #Chemo, #Cystectomy in Localized #Bladder #Cancer https://shar.es/aaVHSA #oncology 12-Jan-19 12:53 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/following-bb2121-novel-car-tcell-product-shows-potential-in-myeloma Following #bb2121, Novel #CAR T-Cell Product Shows Potential in #Myeloma https://shar.es/aaVHVK #oncology 12-Jan-19 12:54 Open Tweet
@CancerWallonia 0 https://www.onclive.com/web-exclusives/daratumumabvrd-regimen-has-practicechanging-potential-in-myeloma #Daratumumab/VRd Regimen Has Practice-Changing Potential in #Myeloma https://shar.es/aaVHPU #oncology 12-Jan-19 12:54 Open Tweet
@UnitedvrgI 0 https://goo.gl/fb/YSw6Ae Cancer: Principles & Practice of #Oncology. Cancer of the Breast 10th Edition (2016) (Epub… https://goo.gl/fb/YSw6Ae 12-Jan-19 14:53 Open Tweet
@MattSherer2 0 https://www.linkedin.com/feed/update/urn:li:activity:6489885459588673536 #oncology #healthcare #cancer #medicine #cancerresearch https://lnkd.in/esTv92V 12-Jan-19 16:08 Open Tweet
  • @CancerWallonia
    12-Jan-19 12:51 Open Tweet
    0 shares
    • https://www.onclive.com/publications/oncology-live/2019/vol-20-no-1/costimulatory-agonists-start-to-bear-fruit-in-oncology
    • #Costimulatory #Agonists Start to Bear Fruit in #Oncology (followed by Marc #Lacroix, #Wallonia) https://shar.es/aaVH9T
  • @CancerWallonia
    12-Jan-19 12:51 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/expert-explores-future-of-cdk46-inhibitors-in-breast-cancer
    • Expert Explores Future of #CDK4/6 #Inhibitors in #Breast #Cancer https://shar.es/aaVHFb #oncology
  • @CancerWallonia
    12-Jan-19 12:52 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/pomalidomide-shows-benefit-in-lenalidomiderefractory-myeloma
    • #Pomalidomide Shows Benefit in #Lenalidomide-Refractory #Myeloma https://shar.es/aaVHRG #oncology
  • @CancerWallonia
    12-Jan-19 12:52 Open Tweet
    0 shares
    • https://www.onclive.com/publications/special-issues/2019/inhibition-of-the-bcl-2-pathway-in-hematologic-malignancies/targeting-bcl2-in-hematologic-malignancies
    • Targeting #BCL-2 in #Hematologic #Malignancies https://shar.es/aaVHBx #oncology
  • @CancerWallonia
    12-Jan-19 12:53 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/few-unanswered-questions-remain-for-nonmetastatic-prostate-cancer
    • Few Unanswered Questions Remain for #Nonmetastatic #Prostate #Cancer https://shar.es/aaVHTA #oncology
  • @CancerWallonia
    12-Jan-19 12:53 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/expert-discusses-neoadjuvant-chemo-cystectomy-in-localized-bladder-cancer
    • Expert Discusses #Neoadjuvant #Chemo, #Cystectomy in Localized #Bladder #Cancer https://shar.es/aaVHSA #oncology
  • @CancerWallonia
    12-Jan-19 12:54 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/following-bb2121-novel-car-tcell-product-shows-potential-in-myeloma
    • Following #bb2121, Novel #CAR T-Cell Product Shows Potential in #Myeloma https://shar.es/aaVHVK #oncology
  • @CancerWallonia
    12-Jan-19 12:54 Open Tweet
    0 shares
    • https://www.onclive.com/web-exclusives/daratumumabvrd-regimen-has-practicechanging-potential-in-myeloma
    • #Daratumumab/VRd Regimen Has Practice-Changing Potential in #Myeloma https://shar.es/aaVHPU #oncology
  • @UnitedvrgI
    12-Jan-19 14:53 Open Tweet
    0 shares
    • https://goo.gl/fb/YSw6Ae
    • Cancer: Principles & Practice of #Oncology. Cancer of the Breast 10th Edition (2016) (Epub… https://goo.gl/fb/YSw6Ae
  • @MattSherer2
    12-Jan-19 16:08 Open Tweet
    0 shares
    • https://www.linkedin.com/feed/update/urn:li:activity:6489885459588673536
    • #oncology #healthcare #cancer #medicine #cancerresearch https://lnkd.in/esTv92V
    Previous1..45678910..16Next
Press   About   Terms of Use   Privacy   Free Weekly Reports   

© The Herd Locker 2016-2019. Bugs, questions or suggestions? Want to track a new hashtag? Just ask.

Loading…